Infanrix IPV + Hib inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

infanrix ipv + hib inj. susp. (pwdr. + solv.) i.m. pre-filled syr. vial

glaxosmithkline biologicals sa-nv - poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose; bordetella pertussis pertactin 8 µg/dose; tetanus toxoid >= 40 iu/dose; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; bordetella pertussis toxoid (pt) 25 µg/dose; diphtheria toxoid (dt) >= 30 iu/dose; conjugate of haemophilus influenzae type b capsular polysaccharide and tetanus toxoid - powder and solvent for suspension for injection - diphteria antigen, adsorbed; haemophilus influenzae type b polysaccharides, conjugated to tetanus toxoid; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus

Boostrix Polio inj. susp. i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

boostrix polio inj. susp. i.m. vial

glaxosmithkline biologicals sa-nv - bordetella pertussis filamentous hemagglutinin (fha) 8 µg/dose; diphtheria toxoid (dt) >= 2 iu/dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; pertactin (bordetella pertussis antigen) 2,5 µg/dose; bordetella pertussis toxoid (pt) 8 µg/dose; tetanus toxoid >= 20 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose - suspension for injection - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

Infanrix IPV inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

infanrix ipv inj. susp. i.m. pre-filled syr.

glaxosmithkline biologicals sa-nv - diphtheria toxoid (dt) >= 30 iu/dose; poliovirus type 2 (inactivated) 8 d-antigen u/0,5 ml; bordetella pertussis filamentous hemagglutinin (fha) 25 µg/dose; poliovirus type 1 (inactivated) 40 d-antigen u/0,5 ml; tetanus toxoid >= 40 iu/dose; bordetella pertussis toxoid (pt) 25 µg/dose; bordetella pertussis pertactin 8 µg/dose; poliovirus type 3 (inactivated) 32 d-antigen u/0,5 ml - suspension for injection - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

Triaxis Polio 0.5 ml inj. susp. i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

triaxis polio 0.5 ml inj. susp. i.m. pre-filled syr.

sanofi pasteur europe s.a. - bordetella pertussis filamentous hemagglutinin (fha) 5 µg/dose; poliovirus type 1 (inactivated) 40 d-antigen u/1 dose; poliovirus type 3 (inactivated) 32 d-antigen u/1 dose; bordetella pertussis pertactin 3 µg/dose; bordetella pertussis toxoid (pt) 2,5 µg/dose; bordetella pertussis purified fimbrial agglutinogens 2 and 3 (fim) 5 µg/dose; diphtheria toxoid (dt) 2 ; poliovirus type 2 (inactivated) 8 d-antigen u/1 dose; tetanus toxoid 20 - suspension for injection - 0,5 ml - diphteria antigen, adsorbed; poliomyelitis virus; tetanus toxoid adsorbed; bordetella pertussis antigen, proteins - diphtheria-pertussis-poliomyelitis-tetanus

PROTECH BRONCHI-SHIELD ORAL BORDETELLA BRONCHISEPTICA LIVE VACCINE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

protech bronchi-shield oral bordetella bronchiseptica live vaccine

boehringer ingelheim animal health australia pty. ltd. - bordetella bronchiseptica - misc. vaccines or anti sera - bordetella bronchiseptica vaccine-microbial active 0.0 u - immunotherapy

QUADRACEL 0.5mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

quadracel 0.5ml injection vial

sanofi-aventis australia pty ltd - tetanus toxoid, quantity: 40 iu; pertussis fimbriae 2 + 3, quantity: 5 microgram; diphtheria toxoid, quantity: 30 iu; poliovirus, quantity: 29 dagu; poliovirus, quantity: 26 dagu; poliovirus, quantity: 7 dagu; pertussis toxoid, quantity: 20 microgram; pertactin, quantity: 3 microgram; pertussis filamentous haemagglutinin, quantity: 20 microgram - injection, suspension - excipient ingredients: polymyxin b sulfate; bovine serum albumin; formaldehyde; phenoxyethanol; glutaral; neomycin; water for injections; polysorbate 80; aluminium phosphate - quadracel is indicated for primary immunisation of children from the age of 2 months to 12 months against diphtheria, tetanus, pertussis, and poliomyelitis.,quadracel is also indicated for the fourth dose for children from 15 months to six years of age who have been immunised previously with three doses of diphtheria, tetanus, pertussis and polio vaccines.

Adacel® Suspension for Injection Singapore - English - HSA (Health Sciences Authority)

adacel® suspension for injection

sanofi-aventis singapore pte. ltd. - (acellular pertussis) filamentous haemagglutinin adsorbed (fha); (acellular pertussis) fimbriae type 2 and 3 adsorbed (fim); (acellular pertussis) pertactin adsorbed (prn); (acelullar pertussis) pertussis toxoid adsorbed (pt); diphtheria toxoid adsorbed; tetanus toxoid adsorbed - injection, suspension - 5 micrograms - (acellular pertussis) filamentous haemagglutinin adsorbed (fha) 5 micrograms; (acellular pertussis) fimbriae type 2 and 3 adsorbed (fim) 5 micrograms; (acellular pertussis) pertactin adsorbed (prn) 3 micrograms; (acelullar pertussis) pertussis toxoid adsorbed (pt) 2.5 micrograms; diphtheria toxoid adsorbed 2 lf; tetanus toxoid adsorbed 5 lf

Infanrix-IPV New Zealand - English - Medsafe (Medicines Safety Authority)

infanrix-ipv

glaxosmithkline nz limited - diphtheria toxoid, adsorbed 60 iu/ml; pertactin 16 µg/ml;  ; pertussis filamentous haemagglutinin 50 µg/ml;  ; pertussis toxoid, adsorbed 50 µg/ml;  ; polio virus type 1 80 dagu/ml;  ; polio virus type 2 16 dagu/ml;  ; polio virus type 3 64 dagu/ml;  ; tetanus toxoid, adsorbed 80 iu/ml - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 60 iu/ml pertactin 16 µg/ml   pertussis filamentous haemagglutinin 50 µg/ml   pertussis toxoid, adsorbed 50 µg/ml   polio virus type 1 80 dagu/ml   polio virus type 2 16 dagu/ml   polio virus type 3 64 dagu/ml   tetanus toxoid, adsorbed 80 iu/ml excipient: aluminium hydroxide neomycin sulfate polymyxin b sulfate sodium chloride water for injection - infanrix®-ipv is indicated for active primary immunisation against diphtheria, tetanus, pertussis, and poliomyelitis. infanrix®-ipv is also indicated as a booster dose for children who have previously been immunised with dtp and polio antigens.

Tetravac, suspension for injection in prefilled syringeDiphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine,(adsorbed). Ireland - English - HPRA (Health Products Regulatory Authority)

tetravac, suspension for injection in prefilled syringediphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine,(adsorbed).

sanofi pasteur - purified tetanus toxoid; purified diphtheria toxoid ph. eur.; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus

Infanrix-IPV+HIB Pdr for Susp for Injection Malta - English - Medicines Authority

infanrix-ipv+hib pdr for susp for injection

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - diphtheria toxoid, tetanus toxoid, bordetella pertussis, pertussis toxoid, filamentous haemagglutinin, fha, pertactin, poliovirus, inactivated, type, mahoney strain, mef, saukett strain, haemophilus influenzae, type b, polysaccharide, polyribosylribitol phosphate - powder for suspension for injection - diphtheria toxoid 30 iu tetanus toxoid 40 iu bordetella pertussis 30 iu pertussis toxoid 25 µg filamentous haemagglutinin (fha) 25 µg pertactin 8 µg poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu haemophilus influenzae type b polysaccharide (polyribosylribitol phosphate) 10 µg - vaccines